Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $45.07 in the prior trading day, Qiagen NV (NYSE: QGEN) closed at $43.93, down -2.53%. In other words, the price has decreased by -$2.53 from its previous closing price. On the day, 1.63 million shares were traded. QGEN stock price reached its highest trading level at $44.36 during the session, while it also had its lowest trading level at $43.8081.
Ratios:
Our goal is to gain a better understanding of QGEN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.08. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.61. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Barclays on June 24, 2025, initiated with a Overweight rating and assigned the stock a target price of $55.
Robert W. Baird Downgraded its Outperform to Neutral on February 19, 2025, whereas the target price for the stock was revised from $52 to $42.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’25 when Thierry Bernard bought 25,000 shares for $48.80 per share.
ROLAND SACKERS bought 31,423 shares of QGEN for $1,546,257 on Aug 15 ’25. On Aug 14 ’25, another insider, ROLAND SACKERS, who serves as the Officer of the company, bought 18,577 shares for $49.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QGEN now has a Market Capitalization of 9525529600 and an Enterprise Value of 10054958080. As of this moment, Qiagen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.71, and their Forward P/E ratio for the next fiscal year is 17.34. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.56. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.66 while its Price-to-Book (P/B) ratio in mrq is 2.72. Its current Enterprise Value per Revenue stands at 4.929 whereas that against EBITDA is 10.077.
Stock Price History:
The Beta on a monthly basis for QGEN is 0.67, which has changed by -0.028956652 over the last 52 weeks, in comparison to a change of 0.15101504 over the same period for the S&P500. Over the past 52 weeks, QGEN has reached a high of $51.88, while it has fallen to a 52-week low of $37.63. The 50-Day Moving Average of the stock is -8.52%, while the 200-Day Moving Average is calculated to be -1.20%.
Shares Statistics:
The stock has traded on average 1.43M shares per day over the past 3-months and 1258800 shares per day over the last 10 days, according to various share statistics. A total of 216.83M shares are outstanding, with a floating share count of 214.96M. Insiders hold about 0.74% of the company’s shares, while institutions hold 77.90% stake in the company. Shares short for QGEN as of 1756425600 were 6719106 with a Short Ratio of 4.65, compared to 1753920000 on 6598386. Therefore, it implies a Short% of Shares Outstanding of 6719106 and a Short% of Float of 4.6.
Dividends & Splits
In the trailing 12 months, QGEN’s forward annual dividend rate was 0.25, compared to 0.25 this year. Against a Trailing Annual Dividend Yield of 0.005546927The current Payout Ratio is 0.00% for QGEN, which recently paid a dividend on 2025-07-02 with an ex-dividend date of 2025-07-02. Stock splits for the company last occurred on 2017-01-25 when the company split stock in a 962:1000 ratio.
Earnings Estimates
The firm’s stock currently is rated by 10.0 analysts. The consensus estimate for the next quarter is $0.61, with high estimates of $0.64 and low estimates of $0.58.
Analysts are recommending an EPS of between $2.76 and $2.32 for the fiscal current year, implying an average EPS of $2.37. EPS for the following year is $2.56, with 15.0 analysts recommending between $2.96 and $2.4.
Revenue Estimates
10 analysts predict $525.68M in revenue for the current quarter. It ranges from a high estimate of $527.3M to a low estimate of $524M. As of the current estimate, Qiagen NV’s year-ago sales were $501.87MFor the next quarter, 10 analysts are estimating revenue of $540.09M. There is a high estimate of $547.6M for the next quarter, whereas the lowest estimate is $532.17M.
A total of 17 analysts have provided revenue estimates for QGEN’s current fiscal year. The highest revenue estimate was $2.1B, while the lowest revenue estimate was $2.04B, resulting in an average revenue estimate of $2.08B. In the same quarter a year ago, actual revenue was $1.98BBased on 17 analysts’ estimates, the company’s revenue will be $2.2B in the next fiscal year. The high estimate is $2.25B and the low estimate is $2.17B.
